As of October 2026 Caliway Biopharmaceuticals has a market cap of NZ$6.44 Billion. This makes Caliway Biopharmaceuticals the world's 3744th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.